pH-responsive hybrid hydrogels: Chondroitin sulfate/casein trapped silica nanospheres for controlled drug release

Int J Biol Macromol. 2020 Apr 1:148:302-315. doi: 10.1016/j.ijbiomac.2020.01.093. Epub 2020 Jan 10.

Abstract

In this study, the materials were synthesized by chemically crosslinking chondroitin sulfate (CS), casein (CAS), and silica nanospheres (SiO2), creating a highly crosslinked network. The hydrogel release profile was adaptable (that is, it could be faster or slower as needed) simply by changing the polymeric proportion. The incorporation of 5% of silica nanospheres, in mass, for all CAS/CS matrices promoted a better-controlled and sustained release of l-dopa, focusing on the matrix based on 70% of CAS, 30% of CS and 5% of silica, whose l-dopa release lasted for 87 h. Besides, hydrogels are cytocompatible. These new hydrogels can be considered highly attractive materials to be used for controlled and sustained drug release purposes, as well as scaffolds and wound dressing systems.

Keywords: Casein; Chondroitin sulfate; Drug delivery device; Parkinson's disease; Stöber's silica; l-Dopa.

MeSH terms

  • Biocompatible Materials / chemistry
  • Caseins / chemistry*
  • Chondroitin Sulfates / chemistry*
  • Cross-Linking Reagents / chemistry
  • Delayed-Action Preparations / chemistry*
  • Drug Delivery Systems / methods
  • Drug Liberation
  • Hydrogels / chemistry*
  • Hydrogen-Ion Concentration
  • Nanospheres / chemistry*
  • Polyethylene Glycols / chemistry
  • Polymers / chemistry
  • Silicon Dioxide / chemistry*

Substances

  • Biocompatible Materials
  • Caseins
  • Cross-Linking Reagents
  • Delayed-Action Preparations
  • Hydrogels
  • Polymers
  • Polyethylene Glycols
  • Silicon Dioxide
  • Chondroitin Sulfates